Drug delivery device and method for connecting a fluid flowpath

Patent metadata

Field	Value
Publication number	US-11033676-B2
Application number	US-201716323711-A
Country	US
Kind code	B2
Filing date	Aug 8, 2017
Priority date	Aug 8, 2016
Publication date	Jun 15, 2021
Grant date	Jun 15, 2021

Abstract

Provided herein is a fluid pathway connection assembly, e.g., for connecting a fluid flowpath within a drug delivery device for delivery of a medicament to a target site. The fluid pathway connection assembly comprises a hollow needle piercing member, a sleeve fixedly engaged with the piercing member and a pierceable seal configured to sealingly engage the piercing member or the sleeve. Upon, sealing engagement, the piercing member or the sleeve and the pierceable seal form a volume within which a portion of the piercing member is disposed. The fluid pathway connection assembly is activated by relative movement between the piercing member and the pierceable seal and activation causes the piercing member to pierce the pierceable seal, thereby establishing a fluid flowpath through the pierceable seal. Upon incorporation of the assembly into a sealed fluid flowpath, the volume is isolated from the environment and maintains the sterile condition of the portion of the piercing member disposed therein. Also provided herein are drug delivery pumps and methods of operating and assembling the assemblies and pumps described herein.

First claim

What is claimed is:

1. A fluid pathway connection assembly, comprising:
a hollow needle piercing member comprising a bent portion;
a sleeve fixedly engaged with the piercing member, the sleeve comprising a flange portion and an elongated portion, the bent portion of the piercing member disposed within the flange portion of the sleeve; and
a pierceable seal configured to sealingly engage the elongated portion of the sleeve, wherein:
in sealing engagement, the elongated portion of the sleeve and the pierceable seal form a volume within which a portion of the piercing member is disposed;
the fluid pathway connection assembly is activated by relative translation of the sleeve within the pierceable seal and activation causes the piercing member to pierce the pierceable seal, thereby establishing a fluid flowpath through the pierceable seal; and
upon incorporation of the assembly into a sealed fluid flowpath, the volume is isolated from the environment and maintains the sterile condition of the portion of the piercing member disposed therein.

2. The assembly of claim 1 , wherein the hollow needle piercing member is a rigid, hollow needle.

3. The assembly of claim 1 , wherein the sleeve includes side channels to facilitate sterilization.

4. The assembly of claim 1 , wherein the pierceable seal includes one or more sealing ribs for sealingly engaging the piercing member or the sleeve.

5. The assembly of claim 1 , wherein the pierceable seal includes a recess and a tip of the piercing member is disposed within the recess upon establishment of the fluid flowpath through the pierceable seal.

6. The assembly of claim 1 , further comprising a retainer that restricts deformation of the pierceable seal or prevents inadvertent relative movement between the piercing member and the pierceable seal.

7. The assembly of claim 1 , wherein one or more of the piercing member, the sleeve and the pierceable seal includes a vent which allows for evacuation of the volume.

8. The assembly of claim 1 , further comprising a crimp cap for securing the pierceable seal to a drug container.

9. The assembly of claim 1 , wherein the pierceable seal is configured to sealingly engage a drug container.

10. A drug delivery pump, comprising an assembly of claim 1 .

11. A drug delivery pump comprising a pump housing including:
an activation mechanism;
a power and control system;
a drive mechanism including a drug container;
an insertion mechanism for delivering drug fluid to a target;
a fluid pathway connection assembly, comprising:
a hollow needle piercing member comprising a bent portion;
a sleeve fixedly engaged with the piercing member, the sleeve comprising a flange portion and an elongated portion, the bent portion of the piercing member disposed within the flange portion of the sleeve; and
a pierceable seal configured to sealingly engage the elongated portion of the sleeve and the drug container; and

a fluid conduit that fluidly connects the fluid pathway connection assembly to the insertion mechanism,
wherein:
in sealing engagement, the elongated portion of the sleeve and the pierceable seal form a volume within which a portion of the piercing member is disposed;
actuation of the activation mechanism initiates the power and control system, which activates the fluid pathway connection assembly, thereby establishing a fluid flowpath from the drug container through the fluid pathway connection assembly and the fluid conduit to the insertion mechanism, and the drive mechanism, thereby driving drug fluid through the fluid flowpath;
the fluid pathway connection assembly is activated by relative translation of the sleeve within the pierceable seal and activation causes the piercing member to pierce the pierceable seal, thereby establishing a fluid flowpath through the fluid pathway connection assembly; and
the volume is isolated from the environment and maintains the sterile condition of the portion of the piercing member disposed therein.

12. The drug delivery pump of claim 11 , further comprising an on-body sensor.

13. The drug delivery pump of claim 11 , wherein the drug container contains drug fluid.

14. A method of operating a drug delivery pump, the drug delivery pump comprising:
an activation mechanism;
a power and control system;
a drive mechanism including a drug container;
an insertion mechanism for delivering drug fluid to a target;
a fluid pathway connection assembly including a hollow needle piercing member comprising a bent portion, a sleeve fixedly engaged with the piercing member, the sleeve comprising a flange portion and an elongated portion, the bent portion of the piercing member disposed within the flange portion of the sleeve, and a pierceable seal configured to sealingly engage the the elongated portion of the sleeve and the drug container, wherein, in sealing engagement, the elongated portion of the sleeve and the pierceable seal form a volume within which a portion of the piercing member is disposed and which, upon incorporation of the assembly into a sealed fluid pathway, is isolated from the environment and maintains the sterile condition of the portion of the piercing member disposed therein; and
a fluid conduit that fluidly connects the fluid pathway connection assembly to the insertion mechanism, the method comprising:
activating the activation mechanism;
actuating the insertion mechanism;
actuating the fluid pathway connection assembly; and
initiating the power and control system to activate the drive mechanism to drive fluid drug through the drug delivery pump, wherein:
actuating the fluid pathway connection assembly, the actuating including causing relative transition of the sleeve within the pierceable seal and causing the piercing member to pierce the pierceable seal, thereby establishing a fluid flowpath from the drug container through the fluid pathway connection assembly and the fluid conduit to the insertion mechanism, thereby delivering fluid drug to the target.

15. A method of assembling a fluid pathway connection assembly and a drug container, comprising:
providing a fluid pathway connection assembly including a hollow needle piercing member comprising a bent portion, a sleeve comprising a flange portion and an elongated portion, and a pierceable seal configured to sealingly engage the elongated portion of the sleeve, the pierceable seal having a cavity;
inserting, at least partially, the pierceable seal into an end of a drug container;
securely constraining the pierceable seal to the drug container;
disposing, as least partially, the piercing member in the cavity of the pierceable seal;
fixedly securing the piercing member and the sleeve to one another, the bent portion of the piercing member disposed within the flange portion of the sleeve; and
sealingly engaging the pierceable seal and the elongated portion of the sleeve, thereby forming a volume, wherein:
a portion of the piercing member is disposed within the volume, which, upon incorporation of the fluid pathway connection assembly into a sealed fluid flowpath, is isolated from the environment and maintains the sterile condition of the portion of the piercing member disposed therein; and
the fluid pathway connection assembly is activated by relative translation of the sleeve within the pierceable seal and activation causes the piercing member to pierce the pierceable seal,
thereby assembling the fluid connection pathway and the drug container.

Assignees

• Unl Holdings Llc

Inventors

• Dechelette Alexis Marie Adolphe
• Russo Robert S
• Laurence Lawton
• Devitt Shaun R

Classifications

• A61M2205/13

  with means for the detection of operative contact with patient, e.g. lip sensor · CPC title

• A61M2039/0081

  Means for facilitating introduction of a needle in the septum, e.g. guides, special construction of septum · CPC title

• A61M2005/1581

  Right-angle needle-type devices · CPC title

• A61M2005/14256

  with means for preventing access to the needle after use · CPC title

• A61M2005/14252

  with needle insertion means · CPC title